Literature DB >> 22146894

[Diagnosis and treatment of Chlamydia trachomatis infections].

T Meyer1.   

Abstract

Nucleic acid amplification tests are now considered the method of choice to detect Chlamydia trachomatis. These assays have highest sensitivity and also high specificity, comparable to culture. First-void urine is the preferred specimen for urogenital infections of males, whereas vaginal and cervical swabs are at least as effective for testing female lower genital tract infections. Chlamydia point-of-care tests may produce results rapidly without special equipment but lack diagnostic accuracy and thus are unsuitable for routine use. Serology is not useful for detection of acute infections, but may help to identify persistent infections with Chlamydia no longer detectable in swabs or urine specimens. Various guidelines recommend doxycycline and azithromycin for treatment of uncomplicated Chlamydia infection. Alternatively erythromycin, ofloxacin and levofloxacin can be used. Persistent infections usually require treatment for longer periods or by using combinations of different antibiotics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22146894     DOI: 10.1007/s00105-011-2194-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  25 in total

Review 1.  Clinical practice. Genital chlamydial infections.

Authors:  Jeffrey F Peipert
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

2.  Repeated detection of lymphogranuloma venereum caused by Chlamydia trachomatis L2 in homosexual men in Hamburg.

Authors:  T Meyer; R Arndt; A von Krosigk; A Plettenberg
Journal:  Sex Transm Infect       Date:  2005-02       Impact factor: 3.519

3.  Alarmingly poor performance in Chlamydia trachomatis point-of-care testing.

Authors:  Laura van Dommelen; Frank H van Tiel; Sander Ouburg; Elfi E H G Brouwers; Peter H W Terporten; Paul H M Savelkoul; Servaas A Morré; Cathrien A Bruggeman; Christian J P A Hoebe
Journal:  Sex Transm Infect       Date:  2010-10       Impact factor: 3.519

4.  Persistent infection of Chlamydia in reactive arthritis.

Authors:  M Rihl; L Köhler; A Klos; H Zeidler
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

5.  A Chlamydia trachomatis strain with a 377-bp deletion in the cryptic plasmid causing false-negative nucleic acid amplification tests.

Authors:  Torvald Ripa; Peter A Nilsson
Journal:  Sex Transm Dis       Date:  2007-05       Impact factor: 2.830

6.  Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies.

Authors:  Claude-Edouard C Michel; Christopher Sonnex; Christopher A Carne; John A White; Jose Paolo V Magbanua; Elpidio Cesar B Nadala; Helen H Lee
Journal:  J Clin Microbiol       Date:  2007-03-21       Impact factor: 5.948

Review 7.  Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  Robert L Cook; Shari L Hutchison; Lars Østergaard; R Scott Braithwaite; Roberta B Ness
Journal:  Ann Intern Med       Date:  2005-06-07       Impact factor: 25.391

Review 8.  Urine nucleic acid amplification tests for the diagnosis of sexually transmitted infections in clinical practice.

Authors:  Charlotte A Gaydos; Thomas C Quinn
Journal:  Curr Opin Infect Dis       Date:  2005-02       Impact factor: 4.915

9.  Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials.

Authors:  Chuen-Yen Lau; Azhar K Qureshi
Journal:  Sex Transm Dis       Date:  2002-09       Impact factor: 2.830

10.  Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis.

Authors:  Julius Schachter; William M McCormack; Max A Chernesky; David H Martin; Barbara Van Der Pol; Peter A Rice; Edward W Hook; Walter E Stamm; Thomas C Quinn; Joan M Chow
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

View more
  3 in total

Review 1.  [Non-viral sexually transmitted infections - Epidemiology, clinical manifestations, diagnostics and therapy : Part 2: Chlamydia and mycoplasma].

Authors:  P Nenoff; A Manos; I Ehrhard; C Krüger; U Paasch; P Helmbold; W Handrick
Journal:  Hautarzt       Date:  2017-01       Impact factor: 0.751

2.  Performance evaluation of the PelvoCheck CT/NG test kit for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  Thomas Meyer; Christian Klos; Regina Kofler; Annett Kilic; Kristina Hänel
Journal:  BMJ Open       Date:  2016-01-04       Impact factor: 2.692

3.  Consensus by Chinese Expert Panel on Chlamydia trachomatis-Resistant and Chlamydia trachomatis-Persistent Infection.

Authors:  Man-Li Qi; Yuan-Li Guo; Qian-Qiu Wang; Xiang-Sheng Chen; Jian-De Han; Xiao-Hong Su; Wen-Hui Lun; Hao Cheng; Jin-Hua Xu; Hong-Qing Tian; Li Chen; Zhi-Yuan Yao; Wen-Li Feng; Juan Jiang; Ping-Yu Zhou; Xian-Biao Zou; Hong-Hui Xu; Wei-Min Shi; Jun Liu; Lin Zhu; Quan-Zhong Liu
Journal:  Chin Med J (Engl)       Date:  2017-12-05       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.